Expert Working Group for the Canadian Guidelines on Sexually Transmitted Infections

The Public Health Agency of Canada (PHAC) acknowledges the efforts and dedication of the Expert Working Group (EWG) who volunteer their time as authors, advisors and reviewers to maintain and update the content of the Canadian Guidelines on Sexually Transmitted Infections. The recommendations are based on the best available evidence, current clinical practices, and reflect emerging trends and issues in the field.

The EWG is comprised of sexually transmitted infections subject matter experts from the fields of medicine, pharmacology, nursing, laboratory sciences, public health, social sciences and research.

Membership

Jared Bullard, MD, BSc, Associate Medical Director, Cadham Provincial Laboratory; Associate Professor, Departments of Pediatrics & Child Health and Medical Microbiology, University of Manitoba

William A. Fisher, PhD, Distinguished Professor, Departments of Psychology and Obstetrics and Gynaecology, University of Western Ontario, London, ON

Margaret Gale-Rowe, MD, MPH, Manager, STBBI Guidelines, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON

Ian Gemmill, MD, FRCPC, Associate Professor, Departments of Family Medicine and Public Health Sciences, Queen’s University;  Sexual Health Clinic,  Kingston, Frontenac, Lennox and Addington

Jennifer Gratrix, BSN, MHP, Director, STI program, Alberta Health Services

Troy Grennan, MD, Physician Lead, Provincial HIV/STI Program, BC Centre for Disease Control; Clinical Assistant Professor, Division of Infectious Diseases, University of British Columbia

Todd Hatchette, MD, Chief of Service, Division of Microbiology, Queen Elizabeth II Health Science Center, Nova Scotia; Clinical Director for the Queen Elizabeth II Sexually Transmitted Disease Clinic; President, Association of Medical Microbiology and Infectious Disease (AMMI) Canada

Annie-Claude Labbé, MD, FRCPC, Associate Professor, Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université de Montréal; Department of Infectious Diseases and Medical Microbiology, Hôpital Maisonneuve-Rosemont, Montréal, CIUSSS de l’Est-de-l’Île-de-Montréal, QC

Tim T.Y. Lau, PharmD, FCSHP, Pharmacotherapeutic Specialist, Infectious Diseases & Antimicrobial Stewardship, Pharmaceutical Sciences, Vancouver General Hospital; Clinical Associate Professor, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC

Ed Lee, MDCM, Medical Director, Hassle Free Clinic, Toronto, ON

Irene Martin, BSc, Head, Streptococcus and STI Unit, Bacteriology and Enterics Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB

Gina Ogilvie, MD, MSc, FCFP, DrPH, Professor, Faculty of Medicine, University of British Columbia; Canada Research Chair in Global control of HPV related disease and cancer; Senior Public Health Scientist, BC Centre for Disease Control; Senior Research Advisor, BC Women's Hospital and Health Centre, Vancouver, BC

Petra Smyczek, MD, Provincial Medical Director for STI, Alberta Health Services; Medical Director, STI Clinic, Edmonton

Marc Steben, MD, CCFP, FCFP, Family Physician, Groupe de médecine familiale et Clinique Réseau 1851, social and preventive medecine, School of public health, Université de Montréal, Montréal, QC

Mark H. Yudin, MD, MSc, FRCSC, Associate Professor, University of Toronto, Department of Obstetrics, Gynecology, and Reproductive Infectious Diseases, St. Michael's Hospital, Toronto, ON